170 related articles for article (PubMed ID: 18269644)
1. The role of surveillance endoscopy and endosonography after endoscopic ablation of high-grade dysplasia and carcinoma of the esophagus.
Savoy AD; Wolfsen HC; Raimondo M; Woodward TA; Noh K; Pungpapong S; Hemminger LL; Wallace MB
Dis Esophagus; 2008; 21(2):108-13. PubMed ID: 18269644
[TBL] [Abstract][Full Text] [Related]
2. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of conventional endosonography and endoscopic ultrasound-guided fine-needle aspiration in the assessment of patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma who have been referred for endoscopic ablation therapy.
Shami VM; Villaverde A; Stearns L; Chi KD; Kinney TP; Rogers GB; Dye CE; Waxman I
Endoscopy; 2006 Feb; 38(2):157-61. PubMed ID: 16479423
[TBL] [Abstract][Full Text] [Related]
4. Eliminating a need for esophagectomy: endoscopic treatment of Barrett esophagus with early esophageal neoplasia.
Lada MJ; Watson TJ; Shakoor A; Nieman DR; Han M; Tschoner A; Peyre CG; Jones CE; Peters JH
Semin Thorac Cardiovasc Surg; 2014; 26(4):274-84. PubMed ID: 25837538
[TBL] [Abstract][Full Text] [Related]
5. Comparative risk of recurrence of dysplasia and carcinoma after endoluminal eradication therapy of high-grade dysplasia versus intramucosal carcinoma in Barrett's esophagus.
Small AJ; Sutherland SE; Hightower JS; Guarner-Argente C; Furth EE; Kochman ML; Forde KA; Bewtra M; Falk GW; Ginsberg GG
Gastrointest Endosc; 2015 May; 81(5):1158-66.e1-4. PubMed ID: 25650071
[TBL] [Abstract][Full Text] [Related]
6. A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia.
Gossner L; May A; Sroka R; Ell C
Endoscopy; 1999 Jun; 31(5):370-6. PubMed ID: 10433046
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
Foroulis CN; Thorpe JA
Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
[TBL] [Abstract][Full Text] [Related]
8. The impact of endoscopic ultrasound findings on clinical decision making in Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma.
Bulsiewicz WJ; Dellon ES; Rogers AJ; Pasricha S; Madanick RD; Grimm IS; Shaheen NJ
Dis Esophagus; 2014 Jul; 27(5):409-17. PubMed ID: 23016606
[TBL] [Abstract][Full Text] [Related]
9. Patient predictors of histopathologic response after photodynamic therapy of Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
Yachimski P; Puricelli WP; Nishioka NS
Gastrointest Endosc; 2009 Feb; 69(2):205-12. PubMed ID: 18950764
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic follow-up of Barrett's esophagus: protocol and implications.
De Looze D
Acta Gastroenterol Belg; 2000; 63(1):29-35. PubMed ID: 10907316
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of patients with Barrett's esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication.
Guarner-Argente C; Buoncristiano T; Furth EE; Falk GW; Ginsberg GG
Gastrointest Endosc; 2013 Feb; 77(2):190-9. PubMed ID: 23317687
[TBL] [Abstract][Full Text] [Related]
13. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett's esophagus.
Pech O; May A; Günter E; Gossner L; Ell C
Am J Gastroenterol; 2006 Oct; 101(10):2223-9. PubMed ID: 17032186
[TBL] [Abstract][Full Text] [Related]
14. Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy.
Borovicka J; Fischer J; Neuweiler J; Netzer P; Gschossmann J; Ehmann T; Bauerfeind P; Dorta G; Zürcher U; Binek J; Meyenberger C
Endoscopy; 2006 Sep; 38(9):867-72. PubMed ID: 16981102
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma.
Wolfsen HC; Woodward TA; Raimondo M
Mayo Clin Proc; 2002 Nov; 77(11):1176-81. PubMed ID: 12440553
[TBL] [Abstract][Full Text] [Related]
16. [Barrett's esophagus carcinoma].
Messmann H
Praxis (Bern 1994); 2006 Jun; 95(25-26):1029-35. PubMed ID: 16836063
[TBL] [Abstract][Full Text] [Related]
17. Invasive carcinoma after endoscopic ablative therapy for high-grade dysplasia in Barrett's oesophagus.
van Hillegersberg R; Haringsma J; ten Kate FJ; Tytgat GN; van Lanschot JJ
Dig Surg; 2003; 20(5):440-4. PubMed ID: 12900536
[TBL] [Abstract][Full Text] [Related]
18. The endoscopic diagnosis and staging of oesophageal adenocarcinoma.
Bergman JJ
Best Pract Res Clin Gastroenterol; 2006; 20(5):843-66. PubMed ID: 16997165
[TBL] [Abstract][Full Text] [Related]
19. Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection.
Peters F; Kara M; Rosmolen W; Aalders M; Ten Kate F; Krishnadath K; van Lanschot J; Fockens P; Bergman J
Endoscopy; 2005 May; 37(5):418-24. PubMed ID: 15844019
[TBL] [Abstract][Full Text] [Related]
20. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
